Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5983_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •1.1.4 Components of niosome
- •1.1.5 Factors affecting niosomes
- •Preface
- •Abstract
- •1.1 Introduction
- •1.1.1 Why niosome?
- •1.1.2 Advantages of niosome
- •1.1.3 Structure of niosome
- •1.2 Applications of niosome
- •1.2.2 Niosomes for the delivery of therapeutics
- •1.2.3 Niosomes in biomedical applications
- •1.3 Conclusions and future prospects
- •Keywords
- •References
- •Abstract
- •2.1 Introduction
- •2.2 Conclusions
- •Acknowledgments
- •Keywords
- •References
- •Abstract
- •3.1 Introduction
- •3.2.1 Parameters involved in electrospinning process
- •3.2.2 Biomaterials for electrospinning
- •3.3 Electrospun nanofibers as drug delivery systems
- •3.3.1 Blending electrospinning
- •3.3.2 Emulsion electrospinning
- •3.3.3 Coaxial electrospinning
- •3.3.4 Surface modifications
- •3.4 Electrospun nanofibers for tissue engineering
- •3.4.1 Electrospun nanofibers for hard tissue engineering
- •3.5 Cancer diagnosis and therapy
- •3.6 Concluding remarks and future perspectives
- •Keywords
- •References
- •4. Natural Biocarriers for Brain Targeting
- •Abstract
- •4.1 Introduction
- •4.1.1 Central nervous system
- •4.2 Biocarriers
- •4.2.1 Carbohydrates carriers
- •4.2.2 Protein carriers
- •4.2.3 Exosomes
- •4.3 Conclusions and perspectives
- •Keywords
- •References
- •Abstract
- •5.1 Introduction
- •5.2 Synthesis of graphene family nanomaterials
- •5.2.1 Graphene synthesis
- •5.2.2 GO and rGO Syntheses
- •5.2.3 GQd synthesis
- •5.4 Drug delivery and biomedical applications
- •5.4.1 Drug delivery
- •5.4.2 Gene delivery
- •5.4.3 Bioimaging
- •5.4.4 Photothermal therapy
- •5.4.5 Tissue engineering
- •5.5 Summary and future prospect
- •Keywords
- •References
- •6. Nanotechnology in Gene Delivery
- •Abstract
- •6.1 Introduction
- •6.2 Gene delivery
- •6.3 Nanotechnology in gene delivery
- •Keywords
- •References
- •Abstract
- •7.1 Introduction
- •7.2 Additive manufacturing in pharmacology
- •7.2.1 Extrusion-based 3D printing techniques
- •7.2.2 Stereolithography
- •7.2.3 Selective laser sintering
- •7.2.4 Binder jet printing
- •7.3 Most common polymers
- •7.3.1 Natural polymers
- •7.3.2 Synthetic polymers
- •7.3.2.5 Polyvinylpyrrolidone
- •7.4 Common 3D-printed dosage forms
- •7.4.1 Scaffolds
- •7.4.2 Tablets
- •Keywords
- •References
- •7.4.3 Microneedles
- •7.4.4 Capsule
- •7.4.5 Films
- •7.5 Main factors in drug delivery
- •7.5.1 Nature of polymers
- •7.5.2 Matrix permeability
- •7.5.3 Polymer blends
- •7.5.4 Specific surface area
- •7.5.5 Infill density and patterns
- •7.5.6 Pores
- •7.5.7 Cross-linking
- •7.5.8 Coating
- •7.5.9 Core/shell and multicompartment
- •7.6 Final considerations and future perspectives
- •Abstract
- •8.1 Introduction
- •8.2.1 Polymer solution concentration and viscosity
- •8.2.2 Molecular weight of polymer
- •8.2.3 Surface tension
- •8.2.4 Electrical conductivity
- •8.2.5 Applied voltage
- •8.2.6 Feed rate/flow rate
- •8.2.7 Temperature and humidity
- •8.3 Method of preparation for nanofibers
- •8.3.1 Electrospinning
- •8.3.2 Self-assembly
- •8.3.3 Phase separation
- •8.3.4 Drawing of nanofibers
- •8.3.5 Template synthesis
- •8.4 Biomedical applications of nanofibers
- •8.4.1 Wound dressing
- •8.4.2 Tissue engineering
- •8.4.3 In cancer therapy
- •8.4.4 Miscellaneous
- •8.5 Drug delivery application
- •8.5.1 Antihypertensive drug
- •8.5.2 Antimicrobial drug
- •8.5.3 Growth hormone
- •8.5.4 Miscellaneous
- •8.6 Conclusion
- •Keywords
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Tissue engineering
- •9.3 Nanotechnology
- •9.4 Polymeric scaffolds in tissue engineering
- •9.5 Challenges
- •Keywords
- •References
- •Abstract
- •10.1 Introduction
- •10.2 Ideal properties of bioceramics
- •10.2.1 Mechanical property
- •10.2.2 Porosity, pore size, and shape
- •10.2.3 Biocompatibility and biodegradability
- •10.2.4 Osteoconductivity and osseointegrity
- •10.3 Bioceramics in orthopedic applications
- •10.4 Bioceramics in maxillofacial surgery
- •10.5 Bioceramic in drug delivery applications
- •10.6 Doped bioceramic in biomedical application
- •10.7 Conclusions
- •10.8 Future direction
- •Acknowledgments
- •Keywords
- •References
- •Index

58
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
REFERENCES
Ultrason. Sonochem.
2022, 82
and in Vivo Study. Eur. J. Pharmacol. 2019, 858
Breast Cancer Res. Treat. 2021, 188
Trials 2019, 20
J. Med. Internet Res. 2019, 21
Mater. Chem.
Phys. 2021, 272
Ann. Intern. Med. 2015,
162
IET Nanobiotechnol. 2022,
Sistemas
Circulation
2015, 131
Antioxidants 2022, 11
antiox11030547.

Advances for Medical Applications in Breast Cancer and Cardiotoxicity
59
PharmaNutrition 2021, 16
phanu.2021.100259.
Lucidum on Cardiovascular and Metabolic Disease Risk. Pharm. Biol. 2021, 59 (1),
Am. J. Physiol. - Hear. Circ. Physiol. 2017, 312
Structure, Stability and in Vitro Gastrointestinal Digestion. Food Hydrocoll. 2020, 99
Hyaluronan-Coated PLGA Nanoparticles: Physico-Chemical Properties and in Vitro
Anticancer Features. Int. J. Biol. Macromol. 2019, 132,
Mater. Sci. Eng. C 2017, 80,
as a Preservative in Bread. Food Hydrocoll. 2020, 99
Clin. Breast Cancer 2017, 17 (4), 272–278.
Disease: Associations and Relations. Eur. J. Heart Fail. 2019, 21
Mater.
Res. Express 2020, 7
Breast Cancer: ONCORE Study Protocol. BMC Cardiovasc. Disord. 2021, 21 (1), 1–12.
Cancer Med. 2016, 5

60
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Biotechnol. Appl. Biochem. 2022, No.
BMC Cancer 2020, 20
J. Agric. Food Chem. 2005, 53 (13),
Food Hydrocoll. 2020, 99 (March 2019),
Biomed. Pharmacother. 2021, 140
Ann. Oncol. 2016, 27 (5),
Australia Position Statement: Exercise Medicine in Cancer Management. J. Sci. Med. Sport
2019, 22
Cardiovascular Prevention and Rehabilitation. Arq. Bras. Car diol. 2014, 103 (103(2Supl.1)).
Bull.
Cancer 2019, 106
Cell Metab. 2018, 27
Acta Oncol (Madr). 2014, 53
186X.2013.781673.
Molecules 2014, 19, 19610–19632.

Advances for Medical Applications in Breast Cancer and Cardiotoxicity
61
World Cancer Day 2021: Spotlight on IARC
Research Related to Breast Cancer
BMC Cancer 2017, 17
s12885-017-3420-4.
J. Clin. Oncol.
2016, 34
I Diretriz Brasileira de Cardio-Oncologia Da Sociedade Brasileira de Cardiologia 2011,
96, 1–52.
Cancer Treat. Rev. 2022, 105,
ctrv.2022.102375.
Survivors. J. Oncol. 2015, 2015
Breast Cancer Res. Treat. 2018,
167
Study. J. Am. Coll. Nutr. 2011, 30, 37–41.
Co-Delivery Farnesol-Gingerol Niosomal Formulation to Enhance Anticancer Activities
against Breast Cancer Cells. J. Drug Deliv. Sci. Technol. 2022, 72
Int. J. Mol. Sci. 2021, 22
BMC Cancer 2019, 19 (1), 1–9.
Int.
J. Cardiovasc. Sci. 2017, 30

62
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Int. J. Biol. Macromol.
2020, 164,
Colloids Surfaces A 2019, 581
Med Sci Sport. Exerc. 2019, 51
MSS.0000000000001937.Physical.
Circulation 2018, 137 (8),
Nanoengineering
of Biomaterials Nanoengineering of Biomaterials Volume I – Drug Delivery
Breast Cancer Res. Treat.
2018a, 168
Breast Cancer Res. Treat. 2018b, 169
by Doxorubicin in Rat. Biochim. Biophys. Acta - Mol. Basis Dis. 2020, 1866 (5), 165665.
Rev. Interdiscip.
Estud. em Saúde da UNIARP 2019, 9 (2), 64–73.
Ceram. Int. 2020, 46
Methylcellulose Films Containing Lippia Alba Extract and Silver Nanoparticles. Carbohydr.
Polym. 2018, 192

Advances for Medical Applications in Breast Cancer and Cardiotoxicity
63
Cancer Receiving First-Line Che. BMC Cancer 2018, 18
s12885-018-4992-3.
JACC CardioOncology 2019, 1
Noncommunicable Disease
part5.
Breast Cancer Management. Cancers (Basel). 2021, 13
cancers13010055.
Asian Pacific J.
Cancer Prev. 2019, 20
Evidence-based
Complement. Altern. Med. 2014, 2014
and Oxidative Stress and Improve Myocardial Energy Metabolism in Acute Doxorubicin-
Induced Cardiotoxicity in Rats. Nutrition 2021, 91–92
nut.2021.111350.
Lipid Nanoparticles: A Design and in Vitro Anticancer Study. J. Food Biochem. 2021, 45
Phytomedicine 2020, 70 (November 2019), 153218.
Int. J. Mol. Sci.
2017, 18
Induced Cardiotoxicity in Wistar Rats. Saudi Pharm. J. 2021, 29
Circulation 2018, 137
Ganoderma Lucidum. Nutrients 2021, 13

64
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Nutrients 2011, 3
Anticancer. Agents Med. Chem. 2018, 18
7666171113121246.
J. Pineal Res. 2017, 62
Chemotherapy. Semin. Cancer Biol. 2022, 86
semcancer.2021.08.003.
Doxorubicin Synergistically Enhance Apoptosis via Autophagy-Dependent Reduction
Exp. Mol. Med. 2021, 53 (9),
Carbohydr. Polym. 2022, 288
Nutrients 2010, 2 (12),
Food Res. Int. 2020,
136
J. Drug Deliv. Sci. Technol. 2023,
79
WHO. Global Health Risks. 2009.
Câncer de Mama Agora Forma Mais Comum de Câncer:
OMS Tomando Medidas
Int. J. Biol. Macromol. 2021, 169,
Cardiotoxicity. Biomed. Pharmacother . 2017, 95
biopha.2017.08.118.

Advances for Medical Applications in Breast Cancer and Cardiotoxicity
65
Eur. Heart J. 2016, 37
Pepper (Piper Nigrum L.) Essential Oil Nanoparticles and Its Antitumor Activity on
J. Food Biochem. 2022, 46
Survivors: A Feasibility Study . J. Oncol. 2021, 2021


Advances in Pharmaceutical T echnology for Drug Delivery Systems (PTDDS), Volume 2: Recent Progress
in Biomedical Applications. Sougata Jana (Ed.)
© 2025 Apple Academic Press, Inc. Co-published with CRC Press (Taylor & Francis)
Electrospun Technology for Drug
Delivery and Biomedical Applications
SIMIN NAZARNEZHAD
1
, SEYEDE ATEFE HOSSEINI
2
, and
SAEID KARGOZAR
3
1
2
3
CHAPTER 3
ABSTRACT
drug delivery strategies and other biomedical applications such as tissue
-
Соседние файлы в папке Библиотека им академика М.И. Перельмана
